OVEMOTIDE

Investigational

Description
Sources: https://www.genome.jp/dbget-bin/www_bget?drug+D06627

Ovemotide, a melanoma peptide vaccine that was investigated as an antineoplastic agent. Information about the current use of this compound is not available.

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 18:23:31 GMT 2025` Edited by `admin` on `Mon Mar 31 18:23:31 GMT 2025`
Protein Type	PEPTIDE
Protein Sub Type	T-CELL ANTIGEN
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	704120HM0H
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

OVEMOTIDE

Official Name

English

MPS-21

Preferred Name

English

MELAN-A(AA26-35*A27L))

Common Name

English

(264-L-VALINE)MELANOCYTE PROTEIN PMEL 17 (HUMAN MELANOMA-ASSOCIATED ME20 ANTIGEN)-(256-264)-PEPTIDE

Common Name

English

L-VALINE, L-TYROSYL-L-LEUCYL-L-.ALPHA.-GLUTAMYL-L-PROLYLGLYCYL-L-PROLYL-L-VALYL-L-THREONYL-

Common Name

English

MART-1:26-35(27L) PEPTIDE

Common Name

English

ovemotide [INN]

Common Name

English

(LEU27)-MELAN-A, MART 1 (26-35)

Common Name

English

TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL

Common Name

English

Ovemotide [WHO-DD]

Common Name

English

ELAGIGILTV

Common Name

English

GP100:280-288(288V) PEPTIDE

Common Name

English

OVEMOTIDE [USAN]

Common Name

English

Code System Code Type Description

CAS

181477-91-8